CX-1942
CX-1942 je agonist AMPA receptora.[3][4][5]
![[4-[2,1,3-benzoksadiazol-5-karbonil(metil)amino]cikloheksil] 2-aminoacetat](/wiki/%D0%94%D0%B0%D1%82%D0%BE%D1%82%D0%B5%D0%BA%D0%B0:SID_397224906.png)
| |
| Nazivi | |
|---|---|
| IUPAC naziv
[4-[2,1,3-benzoksadiazol-5-karbonil(metil)amino]cikloheksil] 2-aminoacetat
| |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C16H20N4O4 | |
| Molarna masa | 332,36 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Reference
уреди- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.
- ^ „Clinical methods and pharmaceutical compositions employing ampa receptor antagonists to treat glioblastoma and other cancers”.
- ^ Di-substituted amides for enhancing glutamatergic synaptic responses
